Novel application of drug-coated balloons in coronary heart disease: A narrative review

被引：7

作者：

Wang, Lijin ^{[1
]}

Li, Xiaokang ^{[1
]}

Li, Tian ^{[2
]}

Liu, Lin ^{[3
]}

Wang, Haiyan ^{[4
]}

Wang, Chiyao ^{[1
]}

机构：

[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian, Peoples R China

[2] Fourth Mil Med Univ, Sch Basic Med, Xian, Peoples R China

[3] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, Xian, Peoples R China

[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Struct Heart Dis, Xian, Peoples R China

来源：

FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 10卷

关键词：

coronary heart disease; drug-coated balloon; drug-eluting stent; percutaneous transluminal coronary intervention; CAD; IN-STENT RESTENOSIS; CHRONIC TOTAL OCCLUSION; EVEROLIMUS-ELUTING STENTS; OPTICAL COHERENCE TOMOGRAPHY; TERM CLINICAL-OUTCOMES; BIFURCATION LESIONS; PERCUTANEOUS CORONARY; ARTERY-DISEASE; FOLLOW-UP; RANDOMIZED-TRIAL;

D O I：

10.3389/fcvm.2023.1055274

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The incidence of coronary heart disease (CAD) has soared over the years, and coronary intervention has become an increasingly important therapeutic approach. The past decade has witnessed unprecedented developments in therapeutic medical instruments. Given that drug-coated balloons bring many benefits, they are indicated for an increasing number of conditions. In this article, we review the results of current clinical trials about drug-coated balloons and summarize their safety and clinical progression in different coronary artery diseases, laying the groundwork for basic research, and clinical therapeutics of this patient population.

引用

页数：12

共 50 条

[31] Drug-Coated Balloons for Restenosis Prophylaxis
Speck, U.
Scheller, B.
Hamm, B.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2014, 186 (04): : 348 - 358
[32] Drug-coated balloons in interventional cardiology
Giannini, Francesco
Naim, Charbel
Costopoulos, Charis
Latib, Azeem
Colombo, Antonio
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (10) : 1379 - 1391
[33] Drug-coated balloons: what is the evidence?
Marques, Leonardo
Hopf-Jensen, Silke
Mueller-Huelsbeck, Stefan
JOURNAL OF CARDIOVASCULAR SURGERY, 2016, 57 (01): : 12 - 17
[34] Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?
Mohamed M. Gad
Antonette K. Karrthik
Ahmad A. Mahmoud
Ahmed N. Mahmoud
Current Cardiology Reports, 2019, 21
[35] The use of drug-coated balloons in the treatment of femoropopliteal and infrapopliteal disease
Li, Jun
Karim, Adham
Shishehbor, Mehdi H.
JOURNAL OF CARDIOVASCULAR SURGERY, 2018, 59 (04): : 512 - 525
[36] Endovascular Treatment with Drug-Coated Balloons in Femoropopliteal Artery Disease
Oz, Ibrahim Ilker
Bilici, Muammer
Altinbas, Namik Kemal
Oz, Evrim Bozay
Caglar, Emrah
IRANIAN JOURNAL OF RADIOLOGY, 2018, 15 (01)
[37] New technologies in percutaneous coronary interventions: drug-coated balloons Foreword
Kleber, Franz X.
Scheller, Bruno
Serruys, Patrick W.
EUROINTERVENTION, 2011, 7 : K7 - K7
[38] The current status of drug-coated balloons in percutaneous coronary and peripheral interventions
Loh, Joshua P.
Barbash, Israel M.
Waksman, Ron
EUROINTERVENTION, 2013, 9 (08) : 979 - 988
[39] Drug-Coated Balloons for Percutaneous Coronary Intervention Does Coating Matter?
Mukherjee, Debabrata
Mares, Adriana C.
JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (13) : 1544 - 1546
[40] Drug-coated balloons for long lesions in peripheral arterial disease
Li, Jun
Parikh, Sahil A.
JOURNAL OF CARDIOVASCULAR SURGERY, 2017, 58 (05): : 698 - 714

← 1 2 3 4 5 →